Enter your mobile number below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.
Getting the download link through email is temporarily not available. Please check back later.

  • Apple
  • Android
  • Windows Phone
  • Android

To get the free app, enter your mobile phone number.

Buy New
$37.28
Qty:1
  • List Price: $58.00
  • Save: $20.72 (36%)
In Stock.
Ships from and sold by Amazon.com. Gift-wrap available.
Healthcare Investing: Pro... has been added to your Cart
Trade in your item
Get a $2.70
Gift Card.
Have one to sell? Sell on Amazon
Flip to back Flip to front
Listen Playing... Paused   You're listening to a sample of the Audible audio edition.
Learn more
See all 2 images

Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services (McGraw-Hill Finance & Investing) Hardcover – January 6, 2009

3.6 out of 5 stars 7 customer reviews

See all 2 formats and editions Hide other formats and editions
Price
New from Used from
Kindle
"Please retry"
Hardcover
"Please retry"
$37.28
$23.81 $18.00

Excel2016ForDummiesVideo
Excel 2016 For Dummies Video Training
Discover what Excel can do for you with self-paced video lessons from For Dummies. Learn more.
click to open popover

Frequently Bought Together

  • Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services (McGraw-Hill Finance & Investing)
  • +
  • Valuation in Life Sciences: A Practical Guide
Total price: $109.27
Buy the selected items together


Editorial Reviews

From the Back Cover

A prescription for profiting in a multitrillion-dollar industry

The health care market is huge, solid, and growing at the rate of inflation, which suggests above-average returns in the future. Due to its complex structure, it is prone to mispricings that savvy investors can clean up on. And because health care products are generally inelastic, the market is particularly suited to weather economic storms.

If you haven't fully explored your investment options in health care, now is the time to do so.

Health-Care Investing provides a complete overview of the market, giving you the perspective you need to make the right investing decisions the first time around. Divided into two parts, it offers macro views of events that have shaped the industry, along with key information about specific investment options you can use to build your strategy. Inside, you'll find everything you need to know, including

  • Key players and market trends
  • Emerging technologies and services
  • Upcoming changes in domestic health care policies
  • Global issues affecting the state of the industry
  • Value and price drivers in each sector

This thorough and engaging guide contains a unique section listing 18 factors you can use to direct your investments for maximum profit.

From choosing the most suitable investment sector to picking the best stocks, you will find vast profits in the health care market if you have the most accurate, up-to-date information. Health Care Investing will ensure long-term health for your portfolio.

About the Author

Les Funtleyder serves as healthcare strategist for Miller Tabak + Co. He previously managed the health-care portfolio of the Minneapolis-based hedge fund Provident Advisors. Funtleyder makes frequent appearances on CNBC, Bloomberg, and National Public Radio.
NO_CONTENT_IN_FEATURE

New York Times best sellers
Browse the New York Times best sellers in popular categories like Fiction, Nonfiction, Picture Books and more. See more

Product Details

  • Series: McGraw-Hill Finance & Investing
  • Hardcover: 304 pages
  • Publisher: McGraw-Hill Education; 1 edition (January 6, 2009)
  • Language: English
  • ISBN-10: 0071597484
  • ISBN-13: 978-0071597487
  • Product Dimensions: 6.3 x 0.9 x 9.2 inches
  • Shipping Weight: 1.2 pounds (View shipping rates and policies)
  • Average Customer Review: 3.6 out of 5 stars  See all reviews (7 customer reviews)
  • Amazon Best Sellers Rank: #397,629 in Books (See Top 100 in Books)

Customer Reviews

Top Customer Reviews

Format: Hardcover Verified Purchase
Healthcare is such a dynamic field with so much complexity and change that even a seasoned expert must constantly amass new knowledge. As a finance professional who previously worked as a healthcare sector analyst at a prominent Wall Street investment bank, I obtained this book with the goal of complementing my understanding and hopefully, finding some new investment ideas.

Les Funtleyder takes on a rather daunting task: explain everything there is to know about investing in healthcare within a brief 259 pages. I have mixed feelings about his success in accomplishing this goal. While this book has plenty of merit, its good points are countered by some whopping downsides.

The Strengths:
Most healthcare literature is purely about political, administrative, or moral dilemmas, but few sources are purely directed at investment as this. I like the unique, business-minded approach this book takes. The front end of is loaded with facts and statistics relevant to this country's health care crisis. Les does a fair job educating the reader on healthcare's current systemic challenges, and outlines the big game played between the ill, providers of treatment, and the private and governmental insurers. Overall he does a terrific job presenting a great deal of topics in laymen's terms, avoiding most of the technical jargon used in the field. Furthermore, this book is thoroughly researched with an excellent bibliography for further reading. A professional like myself would probably be compelled to look up a few of those sources.

The Weaknesses:
The biggest downside of this book is that it does not have the guts to name names - it does not mention specific companies!
Read more ›
Comment 16 people found this helpful. Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback.
Sorry, we failed to record your vote. Please try again
Report abuse
Format: Hardcover
Waste of time...barely scratches the surface of healthcare, biotech or pharmaceutical investing.
Basic coverage of the healthcare profession, healthcare reform, malpractice, innovations, SEC rules, health insurance companies, more fluff than meat. You may learn as much, if not more, surfing the web for the same answers, that is, if you're looking for those mundane details; picked up from the cited titles in the footnotes. The title should not include "Investing," more like elementary topics of...Though the author does cover some valid subject matter pertaining to valuation and how companies spend on R&D and various aspects in the field, it is barely enough to justify the book's value...door stop.

You'd be much better off reading "Biotechnology Valuation" by Karl D. Keegan & "Valuation in Life Sciences, A Practical Guide" by Boris Bogdan & Ralph Villiger. Titles that more thoroughly discuss valuation & proper assessment in trading biotechs. How to determine company value, cash flows, profitability in various stages of stock issuance and future growth continuity. More a GARP (growth at reasonable prices) Graham and Dodd type analysis.

It is best to research how companies are utilizing share holder capital in R&D (research & development) reflecting high success percentage rates of the funds, income & revenue generated per employee, history of pipeline approvals & continued developmental research of new pipelines (in various phase trial stages), thus creating opportunities for expansion and market dominance over its peers, in order to continue current and future growth.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback.
Sorry, we failed to record your vote. Please try again
Report abuse
Format: Hardcover
I first discovered this book while reviewing the CFA's website - clearly if they recommended it, the book must have it's merits. After reading this book, I'm convinced that it's a must-have for any serious investor. With all the impending health care legislation, the sector can be quite daunting - this book captures the big picture, and provides the reader with the necessary toolkit to make money in this environment.

I look forward to the author's next book.
Comment 2 people found this helpful. Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback.
Sorry, we failed to record your vote. Please try again
Report abuse
Format: Hardcover
This book is incredibly well written and insightful. The world of healthcare investing is extremely dynamic with all the political developments happening right now - many of the old books seem archaic. Funtleyder's take on the sector is the most recent so it seems like the only relevant book out there. I highly recommend this book to anyone looking to gain a fresh perspective on what's going on politically and how that will affect the healthcare sector as it pertains to investment. Funtleyder is also incredibly eloquent, so it's a pleasure to read!
Comment 2 people found this helpful. Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback.
Sorry, we failed to record your vote. Please try again
Report abuse

Set up an Amazon Giveaway

Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services (McGraw-Hill Finance & Investing)
Amazon Giveaway allows you to run promotional giveaways in order to create buzz, reward your audience, and attract new followers and customers. Learn more about Amazon Giveaway
This item: Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services (McGraw-Hill Finance & Investing)